Showing results (2061-2070 of 2,809) with videos related to
Sort By:
Pageof 281
Cytotherapy|February 18, 2026
Advancement in cell and gene therapy research: A 35-year bibliometric perspectiveYuki Kitahara, Hiroaki Koda, Junya Kataoka, et al.Cytotherapy|November 12, 2024
Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disordersDimitrios Mougiakakos, Ranjita Sengupta, Ralf Gold, et al.Cytotherapy|November 21, 2024
Optimizing the procedure for manufacturing clinical-grade genetically manipulated natural killer cells for adoptive immunotherapyHaolong Lin, Shanwei Ye, Shujia Zhang, et al.Cytotherapy|May 29, 2026
Periodontitis therapy using autologous adipose-derived stromal cells: a double-blind randomized controlled clinical trial in an aged canine modelPaul Monsarrat, Sara Laurencin-Dalicieux, Géraldine Jourdan, et al.Cytotherapy|May 25, 2026
Yeast surface display meets immunotherapy: unlocking the potential of T cellsJie Wang, Yukun Li, Jinglong Shi, et al.Cytotherapy|May 14, 2026
Targeting intratumoral heterogeneity in pancreatic cancer with sequential TIL infusionsLucas C M Arruda, Julia Karbach, Dragan Kiselicki, et al.Cytotherapy|June 4, 2013
A non-enzymatic method for isolating human adipose tissue-derived stromal stem cellsForum S Shah, Xiying Wu, Marilyn Dietrich, et al.Cytotherapy|June 8, 2026
Curative treatment for severe sickle cell disease: allogeneic hematopoietic cell transplant or gene therapyMary Eapen, David A WilliamsCytotherapy|June 4, 2026
A novel method for efficient murine regulatory T-cell expansion and retroviral transductionCameron McDonald-Hyman, Pooja Shree Marri Baskar, Yiyun Peng, et al.Cytotherapy|June 4, 2026
Rethinking CAR-T manufacturing paradigms: terminology, operational considerations, and economic trade-offsChase McCann, Jacob Matriccino, Mark Lowdell, et al.Pageof 281